[68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR)
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Prostate Cancer|Colorectal Cancer|Non Small Cell Lung Cancer|Small Cell Lung Cancer
Interventions: DRUG: [68Ga]-NeoBOMB1
Sponsor: Advanced Accelerator Applications